Sever Pharma Solutions Appoints Linda Rebert as VP Operations
Sever Pharma Solutions, a leading Contract Development and Manufacturing Organization (CDMO) specializing in Controlled-Release Drug Delivery Systems for highly potent drugs, with development and manufacturing facilities in Malmö, Sweden, and Putnam, CT, USA, is pleased to announce the appointment of Linda Rebert as its new VP Operations, effective December 1, 2025.
Linda has been a member of the Sever Pharma Solutions team since 2020, initially leading the QC department. During the past year, she has been responsible for the Engineering and Operational Excellence function.
Linda brings extensive experience from the bioscience and pharmaceutical industries, having previously held management positions at Chr. Hansen and Polypeptide. Her background provides a strong foundation for driving operational excellence and advancing the company’s strategic ambitions.
We are excited to welcome Linda as our new Vice President of Operations. Linda brings a unique blend of deep technical expertise and a proven track record in driving operational excellence. Her leadership will be instrumental as we continue to enhance performance, streamline processes, and scale our capabilities to meet the growing demands of our business.,” says Fredrik Hultenius, CEO of Sever Pharma Solutions.
Linda holds an MSc in Chemical Engineering from Lund University and is certified as a Lean Six Sigma Black Belt, credentials that further strengthen Sever Pharma Solutions’ operational excellence and the ability to drive continuous improvement across the organization.
Sever Pharma Solutions is one of the few CDMOs specializing in controlled release systems for highly potent drugs, offering end-to-end services. The company’s expertise encompasses the development of new products across various stages of development and the manufacturing of commercial products. Sever Pharma Solutions specializes in Polymer-based sustained release dosage forms such as rings and implants, aseptic Fill and Finish of High Potent drug products, and Hot Melt Extrusion as a solubility enhancement solution for poorly soluble drugs.
Total Page Views: 240
